FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
-16.32%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$592M
AUM Growth
+$592M
(-30%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Moderna
MRNA
$9.37B
| $310M | 52.3% | 4,632,149 | – | – |
|
2
Foghorn Therapeutics
FHTX
$286M
| $118M | 19.94% | 12,674,120 | – | – |
|
3
Sana Biotechnology
SANA
$777M
| $104M | 17.57% | 25,001,856 | – | – |
|
|
OMGA
4
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $35.7M | 6.02% | 29,225,579 | – | – |
|
5
Seres Therapeutics
MCRB
$166M
| $21.9M | 3.7% | 23,117,045 | – | – |
|
|
SYRS
6
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $2.78M | 0.47% | 1,293,849 | – | – |
|